Is CURE.CN undervalued or overvalued?
As of 2025-03-22, the Intrinsic Value of Biocure Technology Inc (CURE.CN) is -2.16 CAD. This CURE.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.03 CAD, the upside of Biocure Technology Inc is -7,298.72%. This means that CURE.CN is overvalued by 7,298.72%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -2.16 - -2.16 | -2.16 | -7,298.72% |
DDM - Stable | (1.46) - (8.60) | (5.03) | -16872.4% |
DDM - Multi | (1.58) - (7.53) | (2.65) | -8924.6% |
Market Cap (mil) | 0.31 |
Beta | -0.64 |
Outstanding shares (mil) | 10.44 |
Enterprise Value (mil) | 0.35 |
Market risk premium | 5.10% |
Cost of Equity | 8.27% |
Cost of Debt | 5.00% |
WACC | 7.73% |